Ignarro and Álvarez-Buylla, winners of the Cátedra Santiago Grisolía Award 2006

Apr 28, 2006

Drs. Louis J. Ignarro, of the Department of Molecular and Medical Pharmacology of the University of California in Los Angeles, and Arturo Álvarez-Buylla of the Department of Neurosurgery and the Programme on Developmental Biology and Stem Cells of the Faculty of Medicine of the University of California in San Francisco, have been awarded the Cátedra Santiago Grisolía prize 2006, organised by the City of Arts and Sciences Foundation.

Both of the prize winners shall be giving a lecture between the 2nd and the 4th of May at the Santiago Grisolía Auditorium in the Príncipe Felipe Science Museum on the research that has led them to win these awards. Dr. Louis J. Ignarro will speak on "Nitrogen oxide as a unique signalling molecule", while Dr. Arturo Álvarez-Buylla will speak on "New neurones in the adult brain".

Dr. Ignarro received the Nobel Prize for Medicine in 1998, shared with Ferid Murad and Robert F. Furgchott, for the discovery of nitrogen oxide (NO) as a signalling molecule in biological processes and for observations of NO as a vasodilator and inhibitor of platelet aggregation. His current research centres on various aspects of metabolism and the function of nitrogen oxide and cyclic GMP. One of the applications of the control mechanisms for blood vessels discovered by Ignarro, Furgchott and Murad is the development of the drug Viagra for treatment of erectile dysfunction. 

Dr. Álvarez-Buylla is a pioneer in the study of neurogenesis in the adult brain and in the discovery and identification of stem cells within it. His studies on neurogenesis mechanisms n adults has provided vital information on the nature of nervous stem cells, as well as on the way young neurones migrate and orientate themselves over enormous distances. His research has also furthered knowledge of the possible functions of neurone replacement by new nerve cells.

The Santiago Grisolía Chair awards these prizes annually to two researchers who stand out on an international level in the field of scientific research, especially in Biomedicine and Neuroscience. They acknowledge research work that is both of high scientific and social interest.